LANTERN PHARMA INC (LTRN) Stock Analyst Ratings
NASDAQ:LTRN - Nasdaq - US51654W1018 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to LTRN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 22.44. This target is 513.11% above the current price.
LTRN was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about LTRN.
In the previous month the buy percentage consensus was at a similar level.
LTRN was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-25 | HC Wainwright & Co. | Reiterate | Neutral |
| 2023-08-10 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-06-26 | EF Hutton | Maintains | Buy -> Buy |
| 2023-05-18 | HC Wainwright & Co. | Initiate | Neutral |
| 2023-03-21 | EF Hutton | Reiterate | Buy |
| 2023-02-15 | EF Hutton | Maintains | Buy |
| 2022-11-01 | EF Hutton | Initiate | Buy |
| 2022-03-11 | HC Wainwright & Co. | Maintains | Buy |
| 2021-11-02 | HC Wainwright & Co. | Maintains | Buy |
| 2021-10-07 | HC Wainwright & Co. | Initiate | Buy |